Residual HIV-1 disease in the era of highly active antiretroviral therapy

被引：32
|
作者：
Pomerantz, RJ [1 ]
机构：
[1] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1999年 / 340卷 / 21期
关键词：
D O I：
10.1056/NEJM199905273402110
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1672 / 1674
页数：3
相关论文
共 50 条
  • [1] Residual HIV-1 RNA after highly active antiretroviral therapy - Reply
    Pomerantz, RJ
    Zhang, H
    Dornadula, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09): : 1138 - 1139
  • [2] Illicit drug use and HIV-1 disease progression: A longitudinal study in the era of highly active antiretroviral therapy
    Lucas, GM
    Griswold, M
    Gebo, KA
    Keruly, J
    Chaisson, RE
    Moore, RD
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (05) : 412 - 420
  • [3] Palliative care for HIV disease in the era of highly active antiretroviral therapy
    Barbara Greenberg
    Ruth Mccorkle
    David Vlahov
    Peter A. Selwyn
    Journal of Urban Health, 2000, 77 : 150 - 165
  • [4] Palliative care for hiv disease in the era of highly active antiretroviral therapy
    Greenberg, B
    McCorkle, R
    Vlahov, D
    Selwyn, PA
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2000, 77 (02): : 150 - 165
  • [5] Modeling the Population Level Effects of an HIV-1 Vaccine in an Era of Highly Active Antiretroviral Therapy
    Rida, Wasima
    Sandberg, Sonja
    BULLETIN OF MATHEMATICAL BIOLOGY, 2009, 71 (03) : 648 - 680
  • [6] Modeling the Population Level Effects of an HIV-1 Vaccine in an Era of Highly Active Antiretroviral Therapy
    Wasima Rida
    Sonja Sandberg
    Bulletin of Mathematical Biology, 2009, 71 : 648 - 680
  • [7] Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
    Dornadula, G
    Zhang, H
    VanUitert, B
    Stern, J
    Livornese, L
    Ingerman, MJ
    Witek, J
    Kedanis, RJ
    Natkin, J
    DeSimone, J
    Pomerantz, RJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17): : 1627 - 1632
  • [8] Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
    Pomerantz, RJ
    BIOMEDICINE & PHARMACOTHERAPY, 2001, 55 (01) : 7 - 15
  • [9] Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
    Dinoso, J. B.
    Kim, S. Y.
    Wiegand, A. M.
    Palmer, S. E.
    Gange, S. J.
    Cranmer, L.
    O'Shea, A.
    Callender, M.
    Spivak, A.
    Brennan, T.
    Kearney, M. F.
    Proschan, M. A.
    Mican, J. M.
    Rehm, C. A.
    Coffin, J. M.
    Mellors, J. W.
    Siliciano, R. F.
    Maldarelli, F.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (23) : 9403 - 9408
  • [10] Pregnancy and HIV disease progression during the era of highly active Antiretroviral therapy
    Tai, Jennifer H.
    Udoji, Mercy A.
    Barkanic, Gema
    Byrne, Daniel W.
    Rebeiro, Peter F.
    Byram, Beverly R.
    Kheshti, Asghar
    Carter, Justine D.
    Graves, Cornelia R.
    Raffanti, Stephen P.
    Sterling, Timothy R.
    JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (07): : 1044 - 1052
12345